Senior Director Infectious Diseases
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Senior Director to lead our Infectious Diseases research team, setting strategic direction and identifying novel technological approaches to advance therapies for infectious diseases. In this role, you will guide drug targets from early discovery through clinical development, while representing Regeneron's Infectious Diseases research vision within the broader scientific community, cross-functional forums, and to senior leadership.
Job description
Discover your role
- Build, develop, and directly supervise the Infectious Diseases research team, providing strategy, vision, and both short-term and long-term goals
- Communicate and align on priorities, policies, and goals between senior leadership and the broader Infectious Disease group
- Identify new strategies or technologies, including antibody engineering, vaccine platforms, and genetic medicines, for pursuing novel infectious disease targets
- Set priorities and drive go/no-go decisions for targets and projects as they move through the development pipeline
- Represent the group's goals and vision in departmental, cross-functional, senior leadership, and external meetings
- Collaborate broadly across therapeutic focus areas and technology groups, forging relationships that advance infectious disease research as a systems-level endeavor
- Mentor the Infectious Diseases group, providing opportunities and challenge to develop team members to their full potential
- Oversee review of infectious diseases-related documents, including regulatory submissions, manuscripts, and contracts
This role requires
- BS/BA degree in a related field required; MS and/or Ph.D./M.D.
- 15+ years of progressive industry/relevant professional experience
- Deep and broad expertise in infectious disease research (e.g., virology, immunology, microbiology, or a related field)
- Familiarity with cutting-edge technologies, including antibody engineering, vaccine platforms, and genetic medicines, with proven experience applying them to infectious disease questions
- Strong leadership, managerial, and mentorship experience, along with experience administratively directing a group (e.g., managing budget and organization)
- Strong written and oral communication skills, with the ability to communicate both science and vision
- Preferred: exposure to drug development or similar regulated activities
- Preferred: broad network of colleagues and collaborators, strong publication record, and national/international reputation
Requirements
- BS/BA degree in a related field required; MS and/or Ph.D./M.D.
- 15+ years of progressive industry/relevant professional experience
- Deep and broad expertise in infectious disease research (e.g., virology, immunology, microbiology, or a related field)
- Familiarity with cutting-edge technologies, including antibody engineering, vaccine platforms, and genetic medicines, with proven experience applying them to infectious disease questions
- Strong leadership, managerial, and mentorship experience, along with experience administratively directing a group (e.g., managing budget and organization)
- Strong written and oral communication skills, with the ability to communicate both science and vision
- Preferred: exposure to drug development or similar regulated activities
- Preferred: broad network of colleagues and collaborators, strong publication record, and national/international reputation
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.